Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» GW Pharma shares dented after cannabinoid drug fails a PhIIa study on focal seizures
GW Pharma shares dented after cannabinoid drug fails a PhIIa study on focal seizures
GW Pharma shares dented after cannabinoid drug fails a PhIIa study on focal seizures
Submitted by
admin
on February 21, 2018 - 11:00pm
Source:
Endpoints
News Tags:
GW Pharma
clinical trials
cannabinoids
Epidiolex
seizures
Headline:
GW Pharma shares dented after cannabinoid drug fails a PhIIa study on focal seizures
Do Not Allow Advertisers to Use My Personal information
